SGHT Sight Sciences, Inc.: institutional ownership and insider trading
123 funds reported holding $150M of Sight Sciences, Inc. in their latest 13F filings; in Q2 2026 funds net sold $2.11M, with 15 new positions and 15 funds selling out; over the last 12 months insiders bought $185K and sold $2.87M on the open market; over its last four quarters it reported revenue of $83.4M and net income of −$29.8M.
SGHT revenue and earnings
- Quarter ended Jun 30, 2026: revenue $23.4M, net income −$4.45M, EPS -0.08
- Quarter ended Mar 31, 2026: revenue $19.7M, net income −$13.0M, EPS -0.24
- Quarter ended Dec 31, 2025: revenue $20.4M, net income −$4.16M, EPS -0.07
- Quarter ended Sep 30, 2025: revenue $19.9M, net income −$8.17M, EPS -0.16
Famous investors holding SGHT
- D. E. Shaw (D. E. Shaw & Co.): $1.52M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $1.17M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $1.15M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $408K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $222K, 0.0% of the portfolio
Largest institutional holders of SGHT
- Long Focus Capital Management, LLC — $20.8M
- BlackRock, Inc. (BLK) — $16.7M
- VANGUARD GROUP INC — $15.5M
- KCK LTD. — $15.0M
- Americana Partners, LLC — $9.10M
- Pathstone Holdings, LLC — $9.10M
- VANGUARD CAPITAL MANAGEMENT LLC — $8.53M
- GEODE CAPITAL MANAGEMENT, LLC — $5.20M
- STATE STREET CORP (STT, STT-PG) — $4.53M
- ACADIAN ASSET MANAGEMENT LLC — $4.36M
Recent SGHT insider trades
- Oct 2, 2026: Rodberg James sold 7,208 shares ($63.8K)
- Oct 2, 2026: Bauerlein Alison sold 25,260 shares ($224K)
- Oct 2, 2026: Taylor Brenton sold 2,988 shares ($26.5K)
- Oct 1, 2026: Badawi Paul sold 29,653 shares ($268K)
5%+ owners
- Staffan Encrantz: 13.1% (Schedule 13D/A, filed Mar 13, 2025)
- LONG FOCUS CAPITAL MANAGEMENT, LLC: 6.0% (Schedule 13G/A, filed May 15, 2025)
- BlackRock, Inc.: 5.0% (Schedule 13G, filed Jan 21, 2026)